HyQvia 2.5g25ml solution for infusion and 1.25ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hyqvia 2.5g25ml solution for infusion and 1.25ml vials

baxalta uk ltd - not applicable

HyQvia 5g50ml solution for infusion and 2.5ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hyqvia 5g50ml solution for infusion and 2.5ml vials

baxalta uk ltd - not applicable

HyQvia 10g100ml solution for infusion and 5ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hyqvia 10g100ml solution for infusion and 5ml vials

baxalta uk ltd - not applicable

HyQvia 20g200ml solution for infusion and 10ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hyqvia 20g200ml solution for infusion and 10ml vials

baxalta uk ltd - not applicable

HyQvia 30g300ml solution for infusion and 15ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hyqvia 30g300ml solution for infusion and 15ml vials

baxalta uk ltd - not applicable

HYQVIA Israel - English - Ministry of Health

hyqvia

takeda israel ltd - human normal immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - replacement therapy in adults, children and adolescents (0-18 years) in:• primary immunodeficiency syndromes with impaired antibody production • hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (cll), in whom prophylactic antibiotics have failed or are contra-indicated.• hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (mm) patients.• hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (hsct).

SUBCUVIA 160 g/l. Solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

subcuvia 160 g/l. solution for injection

baxalta innovations gmbh - human plasma protein >95% immunoglobulins - solution for injection - 160 gram(s)/litre - immunoglobulins, normal human; immunoglobulins, normal human, for extravascular adm. - immune sera and immunoglobulins: immunoglobulins, normal human, for extravascular administration - replacement therapy in adults and children in primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - igg subclass deficiencies with recurrent infections

CUTAQUIG, 165 mg/ml, solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

cutaquig, 165 mg/ml, solution for injection

octapharma (ip) sprl - human normal immunoglobulin - solution for injection - 165 milligram(s)/millilitre - immunoglobulins, normal human; immunoglobulins, normal human, for extravascular adm.

Gammanorm Solution for Injection 165mg/ml (6ml vial) Malta - English - Medicines Authority

gammanorm solution for injection 165mg/ml (6ml vial)

octapharma (ip) limited - immunoglobulin g, human - solution for injection - immunoglobulin g, human 165 mg/ml - immune sera and immunoglobulins

Cuvitru 200 mg/ml solution for subcutaneous injection Ireland - English - HPRA (Health Products Regulatory Authority)

cuvitru 200 mg/ml solution for subcutaneous injection

baxalta innovations gmbh - human normal immunoglobulin - solution for injection - 200 milligram(s)/millilitre - immunoglobulins, normal human, for extravascular adm.